돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 608생성일: 2026년 10월 23일

3-Bromopyridine → Tert-butyl 4-(pyridin-3-YL)piperazine-1-carboxylate

https://huagongshe.com/ko/reaction/608

반응식

참여 물질

역할이름HCID투입량
반응물3-BromopyridineHCID 12286—
반응물tert-Butyl piperazine-1-carboxylateHCID 143452—
시약Sodium t-butoxideHCID 23676156—
촉매Palladium (II) acetateHCID 4144353—
촉매2-Dicyclohexylphosphino-2',6'-diisopropoxybiphenylHCID 16217985—
용매1,4-DioxaneHCID 31275—
생성물Tert-butyl 4-(pyridin-3-YL)piperazine-1-carboxylateHCID 1167337337.96%

반응 조건

온도100 °C

반응 단계

diacetoxypalladium (0.072 g, 0.32 mmol) and RuPhos (0.301 g, 0.64 mmol) were stirred in 1,4-dioxane (11.36 ml) for 10 mins at 50 °C.tert-butyl piperazine-1-carboxylate (0.6 g, 3.22 mmol), 3-bromopyridine (0.310 ml, 3.22 mmol) and sodium tert-butoxide (0.464 g, 4.83 mmol) were added and the reaction mixture was stirred at 100 °C for 64 h. The reaction mixture was filtered through celite. The crude product was purified by flash silica chromatography, elution gradient 20 to 100% EtOAc in heptane. Pure fractions were evaporated to dryness to afford tert-butyl 4-(pyridin-3-yl)piperazine-1-carboxylate (0.322 g, 38.0 %) as a yellow oil which crystallised on standing. This was then combined with EN06111-39-01.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-c9d3e32c4ae3434fab0938e5982b9ebd
출처 메모750 AstraZeneca ELN dataset